Together, we can tackle myopia in children
MiYOSMART
Hello, it looks like you are visiting from United States / Estados Unidos
US
Go to
United States (English)
/
Estados Unidos (español)
site
US
Go to
United States (English)
/
Estados Unidos (español)
site
An estimated 5 billion people, or half the global population could be affected by myopia by 2050*
Myopia is a global concern.
Annual myopia progression rate is most rapid under 10 years of age. Significantly greater rates of progression can be seen especially in children with high myopia.
If left untreated, myopia can lead to lasting vision problems. But together we can tackle myopia in children.
An innovative spectacle lens
This spectacle lens based on revolutionary Defocus Incorporated Multiple Segments (D.I.M.S.) Technology was developed in cooperation with The Hong Kong Polytechnic University in 2014. MiYOSMART is easy to fit, just like regular single vision lens. There are no limitations for the frame choice.
In 2018, the MiYOSMART lens won the Gold Prize, Grand Award & Special Gold Award International Exhibition of Inventions of Geneva, Switzerland. In 2020, it won the Silmo d’Or Award in the Vision category at the Silmo Paris Optical Fair.
A revolutionary technology.
With the exclusive non-invasive D.I.M.S. Technology, the lens corrects the visual defect on its entire surface and has a ring shaped treatment area to slow down myopia progression. The alternation of the focus area and defocus area provides clear vision and manages myopia simultaneously1.
Scientific Evidence of MiYOSMART
2-year Randomized Clinical Trial
Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial (BJO)
3-year Follow-up Study
Myopia management effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study (BJO)
6-year Follow-up Study
Long-term myopia management effect and safety in children wearing DIMS spectacle lenses for 6 years
Overview of MiYOSMART Evidence
Discover the full overview of all MiYOSMART evidence to date. More than 25 publications from across the globe conducted on the MiYOSMART D.I.M.S. Technology over the years.
MiYOSMART Sun - Protect How They See the World
With MiYOSMART Sun, slowing of myopia progression and protection from intense sunlight come together.2-6†
MiYOSMART Sun spectacle lenses adopted D.I.M.S. Technology for effective myopia management and correction of myopic refractive error, while protecting from intense sunlight and increasing eye comfort.2-6
Just like MiYOSMART clear spectacle lenses, MiYOSMART sun spectacle lenses offer 100% protection from UV-A and UV-B,7* reducing the risk of long-term damage to the eye.
*As per EN ISO 8980-3:2013 and ANSI Z80.3-2015 Standards.
††Assuming photochromic spectacle lenses are used at all times or in addition to MiYOSMART clear spectacles lenses, or polarized spectacle lenses are used in addition to MiYOSMART clear spectacle lenses. Patients should always consult their Eye Care Professionals for treatment decisions and instructions for use.
Designed to fit a child’s active life.
MiYOSMART comes with an easy-to-wipe special anti-reflective, durable coating. With its Eye Shield, young patients get the added assurance of an impact resistant material and UV protection.
“Together, we can tackle myopia in children”
Keeping in the know
The Latest News from MiYOSMART
Stay up to date with latest news from MiYOSMART
-
BlogHOYA Vision Care’s Defocus Incorporated Multiple Segments Spectacle Lenses demonstrated a significant trend of myopia control in children
HOYA Vision Care’s Defocus Incorporated Multiple Segments Spectacle Lenses demonstrated significant trend of myopia control in children Interim analysis from the Observational French Study in children presented at EPOS 2024 meeting in Paris
-
ArticleHOYA Vision Care Discusses Confidence in Practice at the WCPOS 2024
HOYA Vision Care participated in the 5th World Congress of Paediatric Ophthalmology and Strabismus in Kuala Lumpur. As a gold sponsor, HOYA hosted a symposium on MiYOSMART lenses, featuring experts discussing the latest research and personalized myopia management strategies.
-
BlogHOYA Vision Care Showcases MiYOSMART Evidence at the Inaugural EURETINA Special Focus Meeting 2024
HOYA Vision Care shared its expertise at the first EURETINA Special Focus Meeting in Paris, co-hosted by the Myopia Society and the French Institute of Myopia.
Disclaimer: MiYOSMART has not been approved for myopia management in all countries, including the U.S., and is not currently available for sale in all countries, including the U.S.
Sources:
- *Holden B.A., Fricke T.R., Wilson D.A., Jong M., Naidoo K.S., Sankaridurg P., Wong T.Y., Naduvilath T.J., Resniko S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. American Academy of Ophthalmology. 05/2016, vol.123, no. 5, p.1036–1042.
- 1. Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. British Journal of Ophthalmology. Published Online First: 29 May 2019. doi: 10.1136/ bjophthalmol-2018-313739
- 2. Ho CL, Wu WF, Liou YM. Dose-Response Relationship of Outdoor Exposure and Myopia Indicators: A Systematic Review and Meta-Analysis of Various Research Methods. Int J Environ Res Public Health. 2019;16(14):2595.
- 3. WSPOS. Sunlight Exposure & Children’s Eyes Consensus Statement. 2016. Available at: https://www.wspos.org/wspos-sunlight-exposure-childrens-eyes-consensus-statement/ (Last accessed 20/02/2023)
- 4. Lakkis C, Weidemann K. Evaluation of the performance of photochromic spectacle lenses in children and adolescents aged 10 to 15 years. Clin Exp Optom. 2006;89(4):246-252.
- 5. Renzi-Hammond LM, Hammond BR Jr. The effects of photochromic lenses on visual performance. Clin Exp Optom. 2016;99(6):568-574.
- 6. Wu PC, Kuo HK. Effect of photochromic spectacles on visual symptoms and contrast sensitivity of myopic schoolchildren treated with low dose concentration atropine. Invest Ophthalmol Vis Sci. 2016;57:2484.
- 7. HOYA data on file. Transmission, traffic light recognition, and UV blocking test for MiYOSMART clear and MiYOSMART sun spectacle lenses. 02/2023. Tests were conducted at room temperature (23°C).